Drugs / Deuterated Water
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT03371680 | Oct 2010 → Dec 2013 | adult acute respiratory distress syndrome, infectious disease with sepsis | University of Padova | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT05729282 Background | Aug 2023 → Sep 2025 | NAFLD1, hyperinsulinism, prediabetes syndrome | Columbia University | Completed | No outcome recorded |
| Phase 1 | NCT01962454 Background | May 2014 → Mar 2015 | hypoproteinemia, hypercatabolic | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Deuterated Water | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01962454 ↗ |
| Route | Oral | “administered per orally” NCT01962454 ↗ |